The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss.The agency first ...

The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no ...

CHICAGO — A shooting inside a car dealership on the city’s Southwest Side left two people injured on Thursday afternoon.

Maryland Attorney General Anthony G. Brown has joined forces with a 37-state coalition to urge the Food and Drug ...

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report payments to healthcare and patient organisations.

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Those who lose weight on Ozempic often find success has left them ... Brannon Claytor, a Bryn Mawr, Pa.-based plastic surgeon who does about 50 body-lift procedures a year.

Cue the advent of Glucagon-like peptide 1 agonists (GLP-1s) such as Ozempic and Wegovy. First approved by the FDA in 2005 for type 2 diabetes, Ozempic showed incredible promise in not only ...

The Department for Work and Pensions overpaid more than £500 million of state pension and pension credit payments into accounts of those who had died over five years (Lucy North/PA) Letters sent ...

FRIDAY, Feb. 7, 2025 (HealthDay News) -- Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the American Academy of Facial Plastic ...

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people with Parkinson’s disease, according to a new study. Researchers ...

GLP-1 agonist jabs, like Mounjaro and Wegovy, reduce people’s appetites. They can also slow down the digestive process. This helps patients to consume fewer calories and get rid of excess weight.